[
    [
        {
            "time": "2018-11-29",
            "original_text": "主力净流入资金最多个股排行|2018年11月29日",
            "features": {
                "keywords": [
                    "主力净流入",
                    "资金",
                    "个股排行"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "主力净流入资金最多个股排行|2018年11月29日",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-11-29",
            "original_text": "云南白药对深交所重组问询函的回复 问询",
            "features": {
                "keywords": [
                    "云南白药",
                    "深交所",
                    "重组",
                    "问询函"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "云南白药对深交所重组问询函的回复 问询",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-11-29",
            "original_text": "云南白药将花不超15.27亿元回购社会公众股 用于股权激励",
            "features": {
                "keywords": [
                    "云南白药",
                    "回购",
                    "股权激励"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "云南白药将花不超15.27亿元回购社会公众股 用于股权激励",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-11-29",
            "original_text": "【医药徐佳熹】医药生物行业2019年投资策略报告——新游戏规则 vs 历史的轮回",
            "features": {
                "keywords": [
                    "医药生物",
                    "投资策略",
                    "2019年",
                    "新游戏规则",
                    "历史轮回"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【医药徐佳熹】医药生物行业2019年投资策略报告——新游戏规则 vs 历史的轮回",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-11-29",
            "original_text": "产业资本大举出手吸筹投资者可以“跟”么？（附股）",
            "features": {
                "keywords": [
                    "产业资本",
                    "吸筹",
                    "投资者",
                    "跟投"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "产业资本大举出手吸筹投资者可以“跟”么？（附股）",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        }
    ]
]